Agomelatine improves memory and learning impairments in a rat model of LPS-induced neurotoxicity by modulating the ERK/SorLA/BDNF/TrkB pathway.

"Declarations Competing interestsThe authors declare no competing interests. Ethics approvalOur experimental protocol was revised and approved by the Ethics Committee of the faculty of pharmacy, Cairo University (Permit No. PT 2659) & the faculty of pharmacy, October University for Modern Sciences and Arts (Permit Code: PH1/Ec1/2020 M.Sc) in accordance with ARRIVE guidelines and the Guide for the Care and Use of Laboratory Animals protocol (National Research Council 2011). Competing interestThe authors declare no competing interests. Competing interests The authors declare no competing interests. Competing interest The authors declare no competing interests."

"Funding Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB)."